Sanofi, Abbott Fail To Halt Release Of Generic Tarka
Sanofi-Aventis Deutschland GmbH and Abbott Laboratories have lost their bid to block Glenmark Ltd. from releasing a recently approved generic version of Abbott's high blood pressure drug Tarka....To view the full article, register now.
Already a subscriber? Click here to view full article